FIELD: medicine; surgery.
SUBSTANCE: for this purpose in case of surgery medicinal agent "Ferrovir" is intramuscularly injected as 1.5% solution in dosage 5.0 ml 2 times a day during 10 days. Conservative ferrovir-based therapy of destructive pancreatitis in specified dosage and injection rate is prescribed in 3 days following enzyme toxemia and systemic inflammatory reaction syndrome relief.
EFFECT: complex normalisation of cytokine state symptoms even against acute destructive process, and reduction of suppurative complication rate.
2 ex, 1 dwg
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR CORRECTION OF DISTURBED STRUCTURAL-FUNCTIONAL PROPERTIES OF RED CELLS AND IMMUNE STATUS IN PATIENTS SUFFERING ACUTE PANCREATITIS | 2011 | 
 | RU2458688C1 | 
| METHOD FOR TREATMENT OF ACUTE DESTRUCTIVE PANCREATITIS | 2006 | 
 | RU2312663C1 | 
| METHOD FOR PREDICTION OF PANCREATIC NECROSIS ACCOMPANYING ACUTE PANCREATITIS | 2024 | 
 | RU2840954C1 | 
| METHOD OF TREATING EXPERIMENTAL PANCREATONECROSIS | 2012 | 
 | RU2525015C2 | 
| METHOD FOR ADJUSTING IMMUNITY DISORDERS BY APPLYING COMBINED ADMINISTRATION OF OZONIZED PHYSIOLOGICAL SALT SOLUTION AND HELIUMNEON LASER TO DESTRUCTIVE PANCREATITIS PATIENTS | 2001 | 
 | RU2194546C2 | 
| METHOD FOR SELECTING A METHOD FOR TREATING ACUTE DESTRUCTIVE PANCREATITIS | 2018 | 
 | RU2683291C1 | 
| METHOD FOR PREDICTING PYOSEPTIC COMPLICATIONS IN PATIENTS POSSESSING ORGAN AND TISSUE INJURIES | 2006 | 
 | RU2314532C1 | 
| METHOD FOR PREDICTING THE OUTCOME OF ACUTE DESTRUCTIVE PANCREATITIS | 2016 | 
 | RU2651030C1 | 
| METHOD OF TREATING PANCREONECROSIS | 2011 | 
 | RU2492527C2 | 
| METHOD FOR THERAPEUTIC APPROACH SELECTION FOR PATIENTS WITH ACUTE DESCTRUCTIVE PANCREATITIS | 2016 | 
 | RU2625742C1 | 
Authors
Dates
2008-06-27—Published
2006-11-21—Filed